Heska Corporation (45)

Browse by Contract Category

Contracts

Amendment No. 1 to Agreement and Plan of Merger dated October 24, 2022 by and among Heska Corporation, Mbio Merger Sub, Inc., Mbio Diagnostics, Inc. and Shareholder Representative... (Filed With SEC on November 8, 2022)
Amendment to Heska Corporation Equity Incentive Plan, effective May 4, 2022 (Filed With SEC on August 8, 2022)
Description of Securities (Filed With SEC on February 28, 2022)
Underwriting Agreement dated March 2, 2021 by and between the Company and J.P. Morgan Securities LLC and Piper Sandler & Co., as representatives of the several underwriters named... (Filed With SEC on March 5, 2021)
Amendment No. 7 to Supply and License Agreement between Registrant and Intervet Inc., d.b.a. Merck Animal Health, effective as of September 18, 2020 (Filed With SEC on November 5, 2020)
Amended and Restated Supply Agreement by and between Registrant and Shenzhen Mindray Bio-Medical Electronics Co., Ltd., effective as of June 1, 2020 (Filed With SEC on August 10, 2020)
Agreement and Plan of Merger dated September 9, 2022 by and among Heska Corporation, Mbio Merger Sub, Inc., Mbio Diagnostics, Inc. and Shareholder Representative Services LLC (Filed With SEC on November 8, 2022)
Heska Corporation Equity Incentive Plan, effective May 5, 2021 (Filed With SEC on August 4, 2021)
Amended and Restated Employment Agreement dated June 8, 2021 by and between Heska Corporation and Kevin Wilson (Filed With SEC on June 10, 2021)
Fourth Amendment to Clinical Chemistry Analyzer Agreement between Registrant and FUJIFILM Corporation, effective as of February 18, 2021 (Filed With SEC on May 6, 2021)
Amended and Restated Management Incentive Plan Master Document (Filed With SEC on February 26, 2021)
Description of Securities (Filed With SEC on February 26, 2021)
Employment Agreement between Registrant and Christopher Sveen, effective as of April 15, 2020 (Filed With SEC on February 26, 2021)
Separation Agreement and Release between Registrant and Jason D. Aroesty, effective as of December 10, 2020 (Filed With SEC on February 26, 2021)
Employment Agreement between Registrant and Eleanor Baker, effective as of April 9, 2020 (Filed With SEC on February 26, 2021)
Employment Agreement between Registrant and Steve Eyl, effective as of April 16, 2020 (Filed With SEC on August 10, 2020)
First Amendment to Exclusive Supply Agreement by and between Registrant and Shenzhen Mindray Bio-Medical Electronics Co., Ltd., effective as of June 1, 2020 (Filed With SEC on August 10, 2020)
2020 Stock Incentive Plan (Filed With SEC on May 8, 2020)
2020 Employee Stock Purchase Plan (Filed With SEC on May 8, 2020)
Registration Rights Agreement dated March 30, 2020 (Filed With SEC on April 1, 2020)
Amendment to the Securities Purchase Agreement dated March 30, 2020 (Filed With SEC on April 1, 2020)
Amendment Agreement dated April 1, 2020 (Filed With SEC on April 1, 2020)
Securities Purchase Agreement, dated as of January 12, 2020, among the Registrant and the purchasers named therein (Filed With SEC on February 28, 2020)
Agreement regarding the sale and purchase of the sole share in scil animal care company GmbH among Registrant, Heska GmbH, Covetrus Animal Health Holdings Limited and Covetrus,... (Filed With SEC on February 28, 2020)
Third Amendment to Clinical Chemistry Analyzer Agreement between Registrant and FUJIFILM Corporation, effective as of August 27, 2019 (Filed With SEC on February 28, 2020)
Separation Agreement and Release between Registrant and Rodney A. Lippincott, effective as of February 4, 2020 (Filed With SEC on February 28, 2020)
Separation Agreement and Release between Registrant and Steven M. Asakowicz, effective as of February 5, 2020 (Filed With SEC on February 28, 2020)
Separation Agreement and Release between Registrant and Jason A. Napolitano, effective as of January 31, 2020 (Filed With SEC on February 28, 2020)
Director Compensation Policy (Filed With SEC on February 28, 2020)
Description of Securities (Filed With SEC on February 28, 2020)
Indenture, dated as of September 17, 2019, by and between the Heska Corporation and U.S. Bank National Association, as Trustee (including the form of the Notes) (Filed With SEC on September 17, 2019)
Amendment No. 1 to the Asset Purchase and License Agreement between Diamond Animal Health, Inc., and Elanco Animal Health, a division of Eli Lilly and Company, effective as of... (Filed With SEC on August 7, 2019)
Amendment No. 1 to the Supplemental Agreement between Elanco US Inc. and Diamond Animal Health, Inc., effective as of June 27, 2019 (Filed With SEC on August 7, 2019)
Heska Corporation Stock Incentive Plan, as amended and restated (Filed With SEC on August 7, 2019)
Amendment No. 2 to the Asset Purchase and License Agreement between Diamond Animal Health, Inc., and Elanco US Inc., effective as of June 27, 2019 (Filed With SEC on August 7, 2019)
Third Amendment to Credit Agreement (Filed With SEC on August 7, 2019)
Stock Incentive Plan Restricted Stock Grant Agreement (Filed With SEC on March 7, 2019)
Termination Agreement between Heska Imaging, LLC and Cuattro, LLC, dated December 18, 2018 (Filed With SEC on March 7, 2019)
Second Amendment to Credit Agreement (Filed With SEC on March 7, 2019)
Stock Incentive Plan Outside Directors Option Agreement (Filed With SEC on March 7, 2019)
Stock Incentive Plan Employees and Consultants Option Agreement (Filed With SEC on March 7, 2019)
Stock Incentive Plan Restricted Stock Grant Agreement (Outside Director Award) (Filed With SEC on March 7, 2019)
Stock Incentive Plan Restricted Stock Grant Agreement (Management Incentive Plan Award) (Filed With SEC on March 7, 2019)
Stock Incentive Plan Restricted Stock Grant Agreement (Performance-based Award) (Filed With SEC on March 7, 2019)
Stock Incentive Plan, as amended and restated (Filed With SEC on March 7, 2019)